Determining INdividual Preferences for Gynecomastia avOidance (DINGO) - Stage 1

Recruiting now · Not applicable

Conditions studied: Prostate Cancer (Adenocarcinoma)

In brief

This study aims to explore the perceptions of men with prostate cancer (PCa) and high-risk biochemical recurrence (BCR) regarding the risk of breast-related side effects, including gynaecomastia, from treatment.

Key facts

Study ID

NCT07552922

Run by

St Vincent's Hospital, Sydney

People needed

24

Starts

2025-12-01

Expected to finish

2026-11-30

Last updated by the study team

2026-04-27

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Men with high-risk BCR PCa but no ADT+/-ARPI experience.
• Men with ADT+/-ARPI experience who have experienced breast-related side effects from this treatment.

You may not qualify if…

• Men receiving psychiatric care as a consequence of their prostate cancer diagnosis or treatment thereof.

Where it is running

• Kinghorn Cancer Centre — Sydney, New South Wales, Australia (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.